Canopy Growth Corporation (CGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.01
+0.00%
Mkt Cap $438.61M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$14.47
Range $8.00 – $27.85
Implied Upside
+1332.7%
Consensus $14.47 vs current $1.01